The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis

Stefano Fiorucci, Elisabetta Antonelli, Andrea Mencarelli, Stefano Orlandi, Barbara Renga, Giovanni Rizzo, Eleonora Distrutti, Vijay Shah, Antonio Morelli

Research output: Contribution to journalArticle

380 Citations (Scopus)

Abstract

The regulation of sinusoidal resistance is dependent on the contraction of hepatic stellate cells (HSC) around sinusoidal endothelial cell (SEC) through paracrine cross-talk of vasoconstrictor and vasodilator agents. Hydrogen sulfide (H2S), a recently discovered gas neurotransmitter, is a putative vasodilator whose role in hepatic vascular regulation and portal hypertension is unexplored. Four-week bile duct-ligated (BDL) rats with cirrhosis and control rats were treated daily with NaHS (56 μmol/kg) for 5 days. Isolated livers were perfused first with NaHS for 20 minutes and then with norepinephrine (NE) and the intrahepatic resistance studied. In normal rats and animals with cirrhosis, administration of NE resulted in a dose-dependent increase of portal pressure. This effect was attenuated by H2S treatment (P < .05). The H2S-induced relaxation of hepatic microcirculation was attenuated by glibenclamide, an adenosine triphosphate (ATP)-sensitive K+ channel inhibitor. L-Cysteine, a substrate of cystathionine-gamma-lyase (CSE), decreased vasoconstriction in normal rat livers (P < .05) but failed to do so in livers with cirrhosis. BDL resulted in a downregulation of CSE mRNA/protein levels and activity (P < .05). Our in vitro data demonstrate that CSE is expressed in hepatocytes, HSCs, but not in sinusoidal endothelial cells (SEC). HSC activation downregulates CSE mRNA expression, resulting in a defective production of H2S and abrogation of relaxation induced by L-cysteine. In conclusion, CSE-derived H2S is involved in the maintenance of portal venous pressure. The reduction of CSE expression in the liver with cirrhosis contributes to the development of increased intrahepatic resistance and portal hypertension.

Original languageEnglish (US)
Pages (from-to)539-548
Number of pages10
JournalHepatology
Volume42
Issue number3
DOIs
StatePublished - Sep 2005

Fingerprint

Cystathionine gamma-Lyase
Liver Cirrhosis
Perfusion
Gases
Pressure
Portal Pressure
Hepatic Stellate Cells
Liver
Portal Hypertension
Bile Ducts
Vasodilator Agents
Cysteine
Norepinephrine
Fibrosis
Down-Regulation
Endothelial Cells
Hydrogen Sulfide
Messenger RNA
Glyburide
Vasoconstrictor Agents

ASJC Scopus subject areas

  • Hepatology

Cite this

Fiorucci, S., Antonelli, E., Mencarelli, A., Orlandi, S., Renga, B., Rizzo, G., ... Morelli, A. (2005). The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology, 42(3), 539-548. https://doi.org/10.1002/hep.20817

The third gas : H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. / Fiorucci, Stefano; Antonelli, Elisabetta; Mencarelli, Andrea; Orlandi, Stefano; Renga, Barbara; Rizzo, Giovanni; Distrutti, Eleonora; Shah, Vijay; Morelli, Antonio.

In: Hepatology, Vol. 42, No. 3, 09.2005, p. 539-548.

Research output: Contribution to journalArticle

Fiorucci, S, Antonelli, E, Mencarelli, A, Orlandi, S, Renga, B, Rizzo, G, Distrutti, E, Shah, V & Morelli, A 2005, 'The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis', Hepatology, vol. 42, no. 3, pp. 539-548. https://doi.org/10.1002/hep.20817
Fiorucci, Stefano ; Antonelli, Elisabetta ; Mencarelli, Andrea ; Orlandi, Stefano ; Renga, Barbara ; Rizzo, Giovanni ; Distrutti, Eleonora ; Shah, Vijay ; Morelli, Antonio. / The third gas : H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. In: Hepatology. 2005 ; Vol. 42, No. 3. pp. 539-548.
@article{5f546017e9c34b23ae9307f77b53a069,
title = "The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis",
abstract = "The regulation of sinusoidal resistance is dependent on the contraction of hepatic stellate cells (HSC) around sinusoidal endothelial cell (SEC) through paracrine cross-talk of vasoconstrictor and vasodilator agents. Hydrogen sulfide (H2S), a recently discovered gas neurotransmitter, is a putative vasodilator whose role in hepatic vascular regulation and portal hypertension is unexplored. Four-week bile duct-ligated (BDL) rats with cirrhosis and control rats were treated daily with NaHS (56 μmol/kg) for 5 days. Isolated livers were perfused first with NaHS for 20 minutes and then with norepinephrine (NE) and the intrahepatic resistance studied. In normal rats and animals with cirrhosis, administration of NE resulted in a dose-dependent increase of portal pressure. This effect was attenuated by H2S treatment (P < .05). The H2S-induced relaxation of hepatic microcirculation was attenuated by glibenclamide, an adenosine triphosphate (ATP)-sensitive K+ channel inhibitor. L-Cysteine, a substrate of cystathionine-gamma-lyase (CSE), decreased vasoconstriction in normal rat livers (P < .05) but failed to do so in livers with cirrhosis. BDL resulted in a downregulation of CSE mRNA/protein levels and activity (P < .05). Our in vitro data demonstrate that CSE is expressed in hepatocytes, HSCs, but not in sinusoidal endothelial cells (SEC). HSC activation downregulates CSE mRNA expression, resulting in a defective production of H2S and abrogation of relaxation induced by L-cysteine. In conclusion, CSE-derived H2S is involved in the maintenance of portal venous pressure. The reduction of CSE expression in the liver with cirrhosis contributes to the development of increased intrahepatic resistance and portal hypertension.",
author = "Stefano Fiorucci and Elisabetta Antonelli and Andrea Mencarelli and Stefano Orlandi and Barbara Renga and Giovanni Rizzo and Eleonora Distrutti and Vijay Shah and Antonio Morelli",
year = "2005",
month = "9",
doi = "10.1002/hep.20817",
language = "English (US)",
volume = "42",
pages = "539--548",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - The third gas

T2 - H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis

AU - Fiorucci, Stefano

AU - Antonelli, Elisabetta

AU - Mencarelli, Andrea

AU - Orlandi, Stefano

AU - Renga, Barbara

AU - Rizzo, Giovanni

AU - Distrutti, Eleonora

AU - Shah, Vijay

AU - Morelli, Antonio

PY - 2005/9

Y1 - 2005/9

N2 - The regulation of sinusoidal resistance is dependent on the contraction of hepatic stellate cells (HSC) around sinusoidal endothelial cell (SEC) through paracrine cross-talk of vasoconstrictor and vasodilator agents. Hydrogen sulfide (H2S), a recently discovered gas neurotransmitter, is a putative vasodilator whose role in hepatic vascular regulation and portal hypertension is unexplored. Four-week bile duct-ligated (BDL) rats with cirrhosis and control rats were treated daily with NaHS (56 μmol/kg) for 5 days. Isolated livers were perfused first with NaHS for 20 minutes and then with norepinephrine (NE) and the intrahepatic resistance studied. In normal rats and animals with cirrhosis, administration of NE resulted in a dose-dependent increase of portal pressure. This effect was attenuated by H2S treatment (P < .05). The H2S-induced relaxation of hepatic microcirculation was attenuated by glibenclamide, an adenosine triphosphate (ATP)-sensitive K+ channel inhibitor. L-Cysteine, a substrate of cystathionine-gamma-lyase (CSE), decreased vasoconstriction in normal rat livers (P < .05) but failed to do so in livers with cirrhosis. BDL resulted in a downregulation of CSE mRNA/protein levels and activity (P < .05). Our in vitro data demonstrate that CSE is expressed in hepatocytes, HSCs, but not in sinusoidal endothelial cells (SEC). HSC activation downregulates CSE mRNA expression, resulting in a defective production of H2S and abrogation of relaxation induced by L-cysteine. In conclusion, CSE-derived H2S is involved in the maintenance of portal venous pressure. The reduction of CSE expression in the liver with cirrhosis contributes to the development of increased intrahepatic resistance and portal hypertension.

AB - The regulation of sinusoidal resistance is dependent on the contraction of hepatic stellate cells (HSC) around sinusoidal endothelial cell (SEC) through paracrine cross-talk of vasoconstrictor and vasodilator agents. Hydrogen sulfide (H2S), a recently discovered gas neurotransmitter, is a putative vasodilator whose role in hepatic vascular regulation and portal hypertension is unexplored. Four-week bile duct-ligated (BDL) rats with cirrhosis and control rats were treated daily with NaHS (56 μmol/kg) for 5 days. Isolated livers were perfused first with NaHS for 20 minutes and then with norepinephrine (NE) and the intrahepatic resistance studied. In normal rats and animals with cirrhosis, administration of NE resulted in a dose-dependent increase of portal pressure. This effect was attenuated by H2S treatment (P < .05). The H2S-induced relaxation of hepatic microcirculation was attenuated by glibenclamide, an adenosine triphosphate (ATP)-sensitive K+ channel inhibitor. L-Cysteine, a substrate of cystathionine-gamma-lyase (CSE), decreased vasoconstriction in normal rat livers (P < .05) but failed to do so in livers with cirrhosis. BDL resulted in a downregulation of CSE mRNA/protein levels and activity (P < .05). Our in vitro data demonstrate that CSE is expressed in hepatocytes, HSCs, but not in sinusoidal endothelial cells (SEC). HSC activation downregulates CSE mRNA expression, resulting in a defective production of H2S and abrogation of relaxation induced by L-cysteine. In conclusion, CSE-derived H2S is involved in the maintenance of portal venous pressure. The reduction of CSE expression in the liver with cirrhosis contributes to the development of increased intrahepatic resistance and portal hypertension.

UR - http://www.scopus.com/inward/record.url?scp=24144458886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24144458886&partnerID=8YFLogxK

U2 - 10.1002/hep.20817

DO - 10.1002/hep.20817

M3 - Article

C2 - 16108046

AN - SCOPUS:24144458886

VL - 42

SP - 539

EP - 548

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 3

ER -